Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Sep. 07, 2024	Sep. 09, 2023
Cash flows from operating activities:
Net income	$ 386.2	$ 684.1
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on property dispositions and impairment losses, net	49.2	19.2
Depreciation and amortization	973.9	945.2
Operating lease right-of-use assets amortization	364.3	357.0
LIFO expense	19.4	60.2
Deferred income tax	(86.7)	(85.8)
Contributions to pension and post-retirement benefit plans, net of expense (income)	(29.3)	(12.1)
Deferred financing costs	8.6	8.4
Equity-based compensation expense	66.2	57.2
Other operating activities	17.0	(12.3)
Changes in operating assets and liabilities:
Receivables, net	(174.0)	(21.3)
Inventories, net	(116.9)	(326.6)
Accounts payable, accrued salaries and wages and other accrued liabilities	88.5	35.1
Operating lease liabilities	(280.6)	(274.7)
Self-insurance assets and liabilities	21.2	40.3
Other operating assets and liabilities	67.1	(126.0)
Net cash provided by operating activities	1,374.1	1,347.9
Cash flows from investing activities:
Payments for property, equipment and intangibles, including lease buyouts	(952.3)	(1,084.3)
Proceeds from sale of assets	19.8	195.1
Other investing activities	7.2	(0.9)
Net cash used in investing activities	(925.3)	(890.1)
Cash flows from financing activities:
Proceeds from issuance of long-term debt, including ABL facility	50.0	50.0
Payments on long-term borrowings, including ABL facility	(200.4)	(500.5)
Payments of obligations under finance leases	(26.9)	(29.1)
Dividends paid on common stock	(139.0)	(138.0)
Dividends paid on convertible preferred stock	0.0	(0.8)
Employee tax withholding on vesting of restricted stock units	(41.5)	(35.1)
Other financing activities	0.0	2.4
Net cash used in financing activities	(357.8)	(651.1)
Net increase (decrease) in cash and cash equivalents and restricted cash	91.0	(193.3)
Cash and cash equivalents and restricted cash at beginning of period	193.2	463.8
Cash and cash equivalents and restricted cash at end of period	$ 284.2	$ 270.5